The National Cancer Institute's intervention trials.

Abstract:

:The National Cancer Institute (NCI) has increased its emphasis in cancer prevention by undertaking a number of human intervention trials. Special emphasis is placed on chemoprevention, diet, and smoking and tobacco use. Some 24 clinical trials are ongoing in chemoprevention to assess the role of specific chemicals (natural and synthetic) in preventing, inhibiting, or reversing carcinogenesis. In diet and nutrition, several macronutrient trials are underway. The most significant of these is examining the relationship between dietary fat and breast cancer. In 1982, the NCI initiated a broad intervention research effort in smoking and tobacco use which has resulted in 46 prevention and clinical trials covering 25 states and more than 200 cities. More recently, a North American community-based intervention trial was begun to test cessation strategies for heavy smokers in 22 different sites. All of these intervention research efforts are testing strategies which later can be applied to large target population thereby supporting NCI's ambitious goal to reduce cancer mortality in this nation 50% by the year 2000.

journal_name

Cancer

journal_title

Cancer

authors

Cullen JW

doi

10.1002/1097-0142(19881015)62:1+<1851::aid-cncr282

subject

Has Abstract

pub_date

1988-10-15 00:00:00

pages

1851-64

issue

8 Suppl

eissn

0008-543X

issn

1097-0142

journal_volume

62

pub_type

临床试验,杂志文章

相关文献

CANCER文献大全
  • Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.

    abstract::Correlations of c-erbB-2 protein expression with clinical outcomes of gastric carcinomas were studied in 189 gastric carcinomas. There were 23 (12.2%) carcinomas with evidence of c-erbB-2 protein in which the reaction was localized to the cell membrane. There was no significant association between c-erbB-2 staining an...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910601)67:11<2914::aid-cncr282

    authors: Yonemura Y,Ninomiya I,Ohoyama S,Kimura H,Yamaguchi A,Fushida S,Kosaka T,Miwa K,Miyazaki I,Endou Y

    更新日期:1991-06-01 00:00:00

  • Application of immunofluorescence for intraoperative evaluation of sentinel lymph nodes in patients with breast carcinoma.

    abstract:BACKGROUND:Sentinel lymph node (SLN) sampling is used to predict axillary lymph node (AxLN) metastasis in patients with breast carcinoma; AxLN sampling can be avoided in SLN-negative patients. Multistep sectioning and immunohistochemistry are reported to increase the sensitivity of micrometastasis detection. The author...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11689

    authors: Munakata S,Aihara T,Morino H,Takatsuka Y

    更新日期:2003-10-15 00:00:00

  • Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.

    abstract:BACKGROUND:Approximately 5% of clear cell renal cell carcinomas contain components with sarcomatoid differentiation. It has been suggested that the sarcomatoid elements arise from the clear cell tumors as a consequence of clonal expansions of neoplastic cells with progressively more genetic alterations. Analysis of the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21288

    authors: Jones TD,Eble JN,Wang M,Maclennan GT,Jain S,Cheng L

    更新日期:2005-09-15 00:00:00

  • Closing the divide: diverse populations and cancer survivorship.

    abstract::Currently, there is a "divide" between cancer survivorship initiatives and minority participation. The level of participation is nearly nonexistent in many cancer support and control initiatives. Cancer survivorship resources that facilitate access to treatment, psychosocial interventions, clinical trials, and researc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21251

    authors: Guidry JJ,Torrence W,Herbelin S

    更新日期:2005-12-01 00:00:00

  • Trioxifene mesylate in the treatment of advanced breast cancer.

    abstract::The efficacy of trioxifene mesylate, a new antiestrogen, in the management of advanced breast cancer was evaluated in 69 patients. Fifty-two patients were randomly allocated to dose schedules of 5 mg, 10 mg, and 20 mg orally twice daily. There were five complete responders (10%), 22 partial responders (42%), and 9 pat...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19860101)57:1<40::aid-cncr282057

    authors: Lee RW,Buzdar AU,Blumenschein GR,Hortobagyi GN

    更新日期:1986-01-01 00:00:00

  • Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?

    abstract:BACKGROUND:Several studies have recently reported on the importance of quality of life (QOL) in predicting the survival of patients with lung carcinoma. To confirm these reports, the relationship between survival and QOL, as measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality of L...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(sici)1097-0142(19990115)85:2<333::aid-cnc

    authors: Herndon JE 2nd,Fleishman S,Kornblith AB,Kosty M,Green MR,Holland J

    更新日期:1999-01-15 00:00:00

  • A multicenter study of the prognosis and treatment of adult brain ependymal tumors.

    abstract:BACKGROUND:The current analysis of outcomes in a large series of adult patients with intracranial ependymal tumors contributes to the characterization of the primary prognostic factors and to the therapeutic management of this rare disease, for which limited information is available in the literature. METHODS:The auth...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.20074

    authors: Reni M,Brandes AA,Vavassori V,Cavallo G,Casagrande F,Vastola F,Magli A,Franzin A,Basso U,Villa E

    更新日期:2004-03-15 00:00:00

  • Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy.

    abstract:BACKGROUND:[(111)In]-diethylenetriamine pentaacetic acid (DTPA)-D-[Phe1]-octreotide (OctreoScan, Mallinckrodt Medical, Petten, The Netherlands), combined with single photon emission computed tomography (SPECT), has limited possibilities to detect small abdominal endocrine tumors. This study explores the efficacy of Oct...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19971215)80:12+<2490::aid-

    authors: Ohrvall U,Westlin JE,Nilsson S,Juhlin C,Rastad J,Lundqvist H,Akerström G

    更新日期:1997-12-15 00:00:00

  • Thymic carcinoid. A histologic, immunohistochemical, and ultrastructural study of 12 cases.

    abstract::Twelve cases of thymic carcinoid were studied by electron microscopy and immunohistochemistry. Clinically, all of them presented either as asymptomatic, radiographically detected mediastinal masses or as neoplasms producing symptoms of thoracic structural displacement or Cushing's syndrome. By light microscopic examin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840201)53:3<475::aid-cncr28205

    authors: Wick MR,Scheithauer BW

    更新日期:1984-02-01 00:00:00

  • Parosteal osteoma of bones other than of the skull and face.

    abstract:BACKGROUND:Osteoma of the skull and facial bones is not uncommon, is usually asymptomatic, and may be associated with Gardner's syndrome. Osteomas involving other bones are unusual. METHODS:The authors describe 14 cases (eight men and six women from age 21-66 years) of parosteal osteoma of bones other than of the skul...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950515)75:10<2466::aid-cncr282

    authors: Bertoni F,Unni KK,Beabout JW,Sim FH

    更新日期:1995-05-15 00:00:00

  • Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors.

    abstract::The percentage of T lymphocytes that form rosettes (RFC) with sheep erythrocytes (E rosettes), cutaneous delayed-type hypersensitivity, and in vitro lymphocyte transformation was measured in 15 patients with primary intracranial tumors. The ability of T lymphocytes to form E rosettes was significantly impaired. Thes...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(197604)37:4<1869::aid-cncr282037

    authors: Brooks WH,Roszman TL,Rogers AS

    更新日期:1976-04-01 00:00:00

  • Testicular Cancer in Children.

    abstract::Management of testis cancer in children differs from that in adults due to the histological types and varying tolerances to chemotherapy agents. Embryonal adrenocarcinoma (endodermal sinus tumor, Teilum's tumor) is a tumor of infancy and young children and less aggressive than other testis cancers. Most cases require ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.1980.45.s7.1803

    authors: Exelby PR

    更新日期:1980-04-01 00:00:00

  • Estrogen receptors in male breast cancer: clinical and pathologic correlations.

    abstract::Breast cancer tissue from 12 male patients was evaluated for the presence of estrogen receptors (ER), and at least 10 of 12 were found to be high in ER (ER+). A combination of previously published cases and our own experience indicates that 80% of patients (37/47) have ER+ tumors. This incidence of ER positivity in me...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810101)47:1<134::aid-cncr28204

    authors: Friedman MA,Hoffman PG Jr,Dandolos EM,Lagios MD,Johnston WH,Siiteri PK

    更新日期:1981-01-01 00:00:00

  • Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy.

    abstract::The authors retrospectively reviewed 50 episodes of spinal epidural tumor that occurred in 42 patients with metastatic prostate cancer and were treated with external-beam radiation. Treatment response was evaluated in terms of symptoms, neurologic status, and, in most cases, reduction of tumor on repeat myelography. A...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820

    authors: Zelefsky MJ,Scher HI,Krol G,Portenoy RK,Leibel SA,Fuks ZY

    更新日期:1992-11-01 00:00:00

  • Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.

    abstract:BACKGROUND:In the phase 3 MARIANNE trial, trastuzumab emtansine (T-DM1) with or without pertuzumab showed noninferior progression-free survival and better tolerability than trastuzumab plus a taxane (HT) for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer. Thi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32392

    authors: Perez EA,Barrios C,Eiermann W,Toi M,Im YH,Conte P,Martin M,Pienkowski T,Pivot XB,Burris HA 3rd,Petersen JA,De Haas S,Hoersch S,Patre M,Ellis PA

    更新日期:2019-11-15 00:00:00

  • Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.

    abstract:BACKGROUND:The authors hypothesized that comprehensive genomic profiling of advanced-stage cutaneous squamous cell carcinoma (cSCC) could identify genomic-derived drug targets of therapy for patients with conventional therapy-resistant disease. METHODS:Comprehensive genomic profiling of 315 cancer genes was applied to...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29738

    authors: Al-Rohil RN,Tarasen AJ,Carlson JA,Wang K,Johnson A,Yelensky R,Lipson D,Elvin JA,Vergilio JA,Ali SM,Suh J,Miller VA,Stephens PJ,Ganesan P,Janku F,Karp DD,Subbiah V,Mihm MC,Ross JS

    更新日期:2016-01-15 00:00:00

  • Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.

    abstract::Two studies were performed to evaluate the safety, tolerability, and efficacy of irinotecan (CPT-11) in the treatment of adults with malignant glioma. Patients with progressive or recurrent malignant gliomas were enrolled. In the first study, CPT-11 was administered once every 3 weeks as a 90-minute intravenous infusi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11306

    authors: Cloughesy TF,Filka E,Kuhn J,Nelson G,Kabbinavar F,Friedman H,Miller LL,Elfring GL

    更新日期:2003-05-01 00:00:00

  • Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia.

    abstract:BACKGROUND:DFP-10917, a deoxycytidine nucleoside analogue, has a unique mechanism of action resulting in leukemic cell death when administered for prolonged periods at low doses. The current phase 1/2 study investigated the safety, maximum tolerated dose, and evidence of antileukemic activity for DFP-10917 administered...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31923

    authors: Kantarjian HM,Jabbour EJ,Garcia-Manero G,Kadia TM,DiNardo CD,Daver NG,Borthakur G,Jain N,Waukau JB,Kwari MI,Ravandi F,Anderson BD,Iizuka K,Jin C,Zhang C,Plunkett WK

    更新日期:2019-05-15 00:00:00

  • Defining a molecular phenotype for benign and malignant parathyroid tumors.

    abstract:BACKGROUND:It is frequently difficult to establish histologically whether a parathyroid tumor is a parathyroid carcinoma, parathyromatosis, or an atypical adenoma. The authors asked whether these tumors have a distinctive molecular profile, whether benign tumors could be distinguished from malignant tumors, and whether...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24037

    authors: Fernandez-Ranvier GG,Khanafshar E,Tacha D,Wong M,Kebebew E,Duh QY,Clark OH

    更新日期:2009-01-15 00:00:00

  • Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.

    abstract::Forty-five patients with advanced non-small cell lung cancer (NSCLC), with progressive inoperable tumors were treated. Twenty-three patients were of "limited" stage. Six patients had received previous thoracic radiotherapy. Patients with central nervous system (CNS) metastases, Karnofsky scores of less than 30 or more...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880101)61:1<14::aid-cncr282061

    authors: Thatcher N,Smith DB,Lind MJ,Anderson H,Barclay J,Chopra MP,Fitzgerald MD

    更新日期:1988-01-01 00:00:00

  • Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.

    abstract:BACKGROUND:Little is understood about the factors that influence survival in patients who undergo gamma-knife stereotactic radiosurgery (SRS) for brain metastases. METHODS:Demographic, disease, treatment, and survival data on 334 patients with intracranial metastases who underwent initial SRS from 1998 to 2004 were ab...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22367

    authors: DiLuna ML,King JT Jr,Knisely JP,Chiang VL

    更新日期:2007-01-01 00:00:00

  • Flexible fiberoptic bronchoscopy in metastatic cancer to the lungs.

    abstract::Seventy-eight patients with metastatic cancer to the lungs underwent flexible fiberoptic bronchoscopy for diagnosis. The patients were divided into two groups by presenting radiographic pattern as: (I) diffuse linear interstitial infiltrations (55 patients); and (II) localized or multiple nodular opacities (23 patient...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19831115)52:10<1949::aid-cncr282

    authors: Chuang MT,Padilla ML,Teirstein AS

    更新日期:1983-11-15 00:00:00

  • Cure rate estimation and long-term prognosis of uterine cervix carcinoma.

    abstract::This paper reports the prognosis results of a retrospective study of over 2000 cases of uterine cervix carcinoma totally treated at Institut Gustave-Roussy from 1950 to 1963. From the study of their long-term survival, an overall cure rate was estimated at 49% seven years after the start of primary treatment. A study ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810101)47:1<203::aid-cncr28204

    authors: Pejovic MH,Wolff JP,Kramar A,Goldfarb E

    更新日期:1981-01-01 00:00:00

  • Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung.

    abstract::This report describes a patient with small-cell carcinoma of the lung associated with blindness. The serum of this patient was tested for immunoreactivity with retinal sections because there was no evidence of tumor metastasis to the central nervous system and because neuroendocrine cells of the lung share common anti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19821001)50:7<1289::aid-cncr2820

    authors: Kornguth SE,Klein R,Appen R,Choate J

    更新日期:1982-10-01 00:00:00

  • Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.

    abstract:BACKGROUND:The degree of response and the duration of survival of patients treated with mitogen-activated protein kinase (MAPK) inhibitors are highly variable. Whether baseline clinicopathologic factors can predict the clinical course with treatment is largely unknown. METHODS:For 142 consecutive immunotherapy- and MA...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29586

    authors: Menzies AM,Wilmott JS,Drummond M,Lo S,Lyle M,Chan MM,Thompson JF,Guminski A,Carlino MS,Scolyer RA,Kefford RF,Long GV

    更新日期:2015-11-01 00:00:00

  • Elevated carcinoembryonic antigen levels in the milk of a nursing mother with inoperable breast cancer.

    abstract::Carcinoembryonic antigen (CEA) determinations performed in the milk of a nursing mother with an inoperable breast cancer revealed a 10-15-fold higher level compared with CEA levels in the milk of healthy nursing women. CEA was highly elevated in the milk of the tumor-bearing breast (1100 +/- 100 ng/ml) and moderately ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801101)46:9<2091::aid-cncr2820

    authors: Bartal AH,Kahana L,Yarom J

    更新日期:1980-11-01 00:00:00

  • Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas?

    abstract::Between 1970 and 1989, 17 children with histologically malignant intracranial ependymomas received treatment at the University of Pennsylvania (Philadelphia, PA). Eleven were treated with prophylactic cranial or craniospinal irradiation plus a local boost (CS-XRT), five with local (L-XRT) irradiation only, and one was...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19910601)67:11<2766::aid-cncr282

    authors: Goldwein JW,Corn BW,Finlay JL,Packer RJ,Rorke LB,Schut L

    更新日期:1991-06-01 00:00:00

  • Evolution of carcinoma in the extrahepatic bile ducts.

    abstract::The histopathology of 43 cases of carcinoma in the extrahepatic bile ducts was reported. All four cases of noninfiltrating carcinoma were papillary or polypoid in gross shape. Only one of the eight cases of papillary or polypoid cancers penetrated beyond the fibromuscular layer of the bile ducts, while most cases of n...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840701)54:1<65::aid-cncr282054

    authors: Kozuka S,Tsubone M,Hachisuka K

    更新日期:1984-07-01 00:00:00

  • The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures.

    abstract::Since 1972 plasma CEA levels of 25 cancer patients have been assayed to evaluate the reliability of CEA as an early indicator of recurrent gastrointestinal cancer. Identification of significant elevations in CEA levels required definition of exactly what a given value meant. Intraassay and interassay accuracy was dete...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197702)39:2<440::aid-cncr2820390

    authors: Martin EW Jr,James KK,Hurtubise PE,Catalano P,Minton JP

    更新日期:1977-02-01 00:00:00

  • A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.

    abstract:BACKGROUND:The phosphatidylinositol-3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is dysregulated in patients with metastatic renal cell carcinoma (mRCC). Buparlisib is a pan-PI3K inhibitor with activity in advanced solid tumors. The primary objective of the current study was to determine the maximum...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.30056

    authors: McKay RR,De Velasco G,Werner L,Bellmunt J,Harshman L,Sweeney C,Rosenberg JE,Hirsch M,Signoretti S,Van Allen EM,Walsh M,Vaishampayan U,McDermott DF,Choueiri TK

    更新日期:2016-08-01 00:00:00